Great Novel Therapeutics Biotech & Medicals (7427.TWO)
TWD 32.85
(-18.69%)
TWD 32.85
(-18.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -54.91 Million TWD | -1.78% |
| 2022 | -53.95 Million TWD | -54.07% |
| 2021 | -35.07 Million TWD | -15.95% |
| 2020 | -30.2 Million TWD | 0.0% |
| 2019 | -28.89 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -30.79 Million TWD | -120.31% |
| 2024 Q2 | -31.52 Million TWD | -2.35% |
| 2023 Q3 | -13.97 Million TWD | 20.72% |
| 2023 FY | - TWD | -1.78% |
| 2023 Q1 | -17.63 Million TWD | 8.04% |
| 2023 Q4 | -13.97 Million TWD | 0.0% |
| 2023 Q2 | -17.63 Million TWD | 0.0% |
| 2022 Q3 | -19.17 Million TWD | 0.0% |
| 2022 FY | - TWD | -54.07% |
| 2022 Q4 | -19.17 Million TWD | 0.0% |
| 2021 FY | - TWD | -15.95% |
| 2020 FY | - TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -18.751% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 113.952% |
| Level Biotechnology Inc. | 98.7 Million TWD | 155.636% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -22.745% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 23.851% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -117.632% |
| GlycoNex Incorporation | -126.82 Million TWD | 56.701% |
| VBI | -6.97 Million TWD | -687.651% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 61.784% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 351.788% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -209.799% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 47.001% |
| Visgeneer Inc. | 973 Thousand TWD | 5743.885% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 83.824% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 105.864% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 155.005% |
| Neith Corporation | -33.61 Million TWD | -63.389% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 94.459% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -3061.485% |
| Enimmune corporation | -228.96 Million TWD | 76.016% |
| TaiRx, Inc. | -208.64 Million TWD | 73.68% |
| CHO Pharma, Inc. | -277.73 Million TWD | 80.227% |
| EirGenix Inc. | -664.4 Million TWD | 91.735% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 174.306% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 179.422% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 94.874% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 51.448% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 257.63% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 11.912% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -108.802% |
| RBC Bioscience Corporation | 36.54 Million TWD | 250.259% |
| BiOptic Inc. | 65.03 Million TWD | 184.435% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 91.953% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -66.379% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 112.666% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 31.418% |
| NaviFUS Corp. | -55.79 Million TWD | 1.577% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -230.853% |
| Sinew Pharma Inc. | -163.63 Million TWD | 66.44% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 10.707% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 128.542% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 75.774% |
| AP Biosciences Inc | -325.51 Million TWD | 83.13% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 94.743% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -53.197% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 288.517% |
| Intech Biopharm Corporation | -219.58 Million TWD | 74.991% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 91.855% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -22.166% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 65.861% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 108.377% |
| TCI GENE Inc. | 25.98 Million TWD | 311.366% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 50.365% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 80.649% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 62.379% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 496.498% |
| PharmaEngine, Inc. | 347.3 Million TWD | 115.812% |
| Savior Lifetec Corporation | 219.6 Million TWD | 125.006% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 131.885% |
| OBI Pharma, Inc. | -855.08 Million TWD | 93.578% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 40.673% |
| Acepodia, Inc. | -764.51 Million TWD | 92.817% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 88.064% |